Literature DB >> 29687849

LncRNA NBAT-1 is down-regulated in lung cancer and influences cell proliferation, apoptosis and cell cycle.

T Lei1, Z-Y Lv, J-F Fu, Z Wang, Z Fan, Y Wang.   

Abstract

OBJECTIVE: To explore the expression and role of lncRNA NBAT-1 in lung cancer. PATIENTS AND METHODS: LncRNA NBAT-1 expression in lung cancer tissues and adjacent areas was detected via reverse transcriptase-polymerase chain reaction (RT-PCR). RAC1 protein was analyzed via Western blotting assay. Cell counting kit-8 (CCK-8) and flow cytometry were used to evaluate cell proliferation and apoptosis as well as cell cycle.
RESULTS: The expression level of lncRNA NBAT-1 in cancer specimen was remarkably lower than that in adjacent areas. Furthermore, the low expression of lncRNA NBAT-1 had a significant correlation with patient's tumor size, differentiation degree of tumor cells and lymph node metastasis. The overexpression of lncRNA NBAT-1 could inhibit the proliferation and cell cycle, promote the apoptosis of A549 cells, and down-regulate the expression level of RAC1.
CONCLUSIONS: The low expression of lncRNA NBAT-1 is involved in the progression of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29687849     DOI: 10.26355/eurrev_201804_14721

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

1.  LncRNA-NBAT-1 modulates esophageal cancer proliferation via PKM2.

Authors:  Bo Zhao; Peng Cao; Shan Hu; Fan Li; Kangle Kong; Yukun Zu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 2.  Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations.

Authors:  Rebecca Morgan; Willian Abraham da Silveira; Ryan Christopher Kelly; Ian Overton; Emma H Allott; Gary Hardiman
Journal:  Expert Rev Mol Diagn       Date:  2021-11-25       Impact factor: 5.225

3.  LncRNA GATA6-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer via Repressing microRNA-543 to Up-Regulating RKIP.

Authors:  Zixuan Gong; Xiaoyu Chen; YueChao Zhang; Cheng Liu; Zhibing Wang; Xiaoyan Xu; Jun Zhu; Tongqing Xue
Journal:  Cancer Manag Res       Date:  2020-09-29       Impact factor: 3.989

4.  LncRNA-ENST00000556926 regulates the proliferation, apoptosis and mRNA transcriptome of malignant-transformed BEAS-2B cells induced by coal tar pitch.

Authors:  Yonghang Zhu; Zhongqiu Li; Weiguang Wang; Linhao Jing; Qi Yu; Zhenkai Li; Xu Chen; Jiatong Zhang; Peng Zhang; Feifei Feng; Qiao Zhang
Journal:  Toxicol Res (Camb)       Date:  2021-11-06       Impact factor: 3.524

5.  Involvement of lncRNA-HOTTIP in the Repair of Ultraviolet Light-Induced DNA Damage in Spermatogenic Cells.

Authors:  Meng Liang; Ke Hu
Journal:  Mol Cells       Date:  2019-11-30       Impact factor: 5.034

Review 6.  An Overview of Long Non-Coding (lnc)RNAs in Neuroblastoma.

Authors:  Francesca Baldini; Matilde Calderoni; Laura Vergani; Paola Modesto; Tullio Florio; Aldo Pagano
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

7.  Long Non-Coding RNA NORAD Inhibits Breast Cancer Cell Proliferation and Metastasis by Regulating miR-155-5p/SOCS1 Axis.

Authors:  Weipeng Liu; Xin Zhou; Yuanqiang Li; Hong Jiang; Aijun Chen
Journal:  J Breast Cancer       Date:  2021-06       Impact factor: 3.588

8.  A negative feedback loop between long noncoding RNA NBAT1 and Sox9 inhibits the malignant progression of gastric cancer cells.

Authors:  Jijun Yan; Wenwei Huang; Xiufang Huang; Wencai Xiang; Chao Ye; Juntao Liu
Journal:  Biosci Rep       Date:  2018-11-15       Impact factor: 3.840

9.  lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.

Authors:  Wei Wei; Xiaoliang Zhao; Jianquan Zhu; Lianmin Zhang; Yulong Chen; Bin Zhang; Yue Li; Meng Wang; Zhenfa Zhang; Changli Wang
Journal:  Oncol Rep       Date:  2019-09-05       Impact factor: 3.906

Review 10.  The Impact of lncRNAs and miRNAs on Apoptosis in Lung Cancer.

Authors:  Soudeh Ghafouri-Fard; Amin Aghabalazade; Hamed Shoorei; Jamal Majidpoor; Mohammad Taheri; Majid Mokhtari
Journal:  Front Oncol       Date:  2021-07-21       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.